| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 |
| filingDate |
2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a041cbd097a64761da9a6cda58472bad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c11255f25807d171857e4bcdd76e7b2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6285ff81b34ac00b110661094af2b12f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47dd39b0be789bfac3af78c1a95b555f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54c8e6b4ceef05fa6631facc31913aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32dd382f4542291d14f4a97b7adf09b4 |
| publicationDate |
2022-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022106279-A1 |
| titleOfInvention |
Class of mu-opioid receptor agonists |
| abstract |
The present invention provides a compound having the structure: n n n n n n n n n n or a pharmaceutically acceptable salt or ester thereof. |
| priorityDate |
2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |